Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Bactiguard Holding AB ( ($SE:BACTI.B) ) is now available.
Bactiguard Holding AB reported a positive EBITDA momentum in the second quarter of 2025, despite a decrease in total revenue and net sales due to currency effects and delays in market registration. The company initiated early feasibility work in the cardiology therapeutic area, which presents significant potential, and continues to focus on strengthening partnerships and driving growth in its strategic areas.
The most recent analyst rating on ($SE:BACTI.B) stock is a Sell with a SEK47.00 price target. To see the full list of analyst forecasts on Bactiguard Holding AB stock, see the SE:BACTI.B Stock Forecast page.
More about Bactiguard Holding AB
Bactiguard Holding AB operates in the medical technology industry, focusing on infection prevention solutions. The company specializes in developing and providing coatings for medical devices to prevent infections, with a significant market focus on partnerships with companies like BD and Zimmer Biomet.
Average Trading Volume: 5,197
Current Market Cap: SEK995.2M
See more data about BACTI.B stock on TipRanks’ Stock Analysis page.